The European Medicines Agency (EMA) has approved the use of Bavarian Nordic’s mpox vaccine in adolescents, increasing the ...

One dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine is moderately effective against mpox infection in at-risk communities.

The European Commission on Friday extended the authorization of the Imvanex mpox vaccine to teenagers aged 12 to 17.

Rwanda has started a vaccination campaign against mpox with 1,000 doses of the vaccine it obtained from Nigeria under an ...

Bavarian's JYNNEOS has also been approved by the U.S. Food and Drug Administration (FDA) but only for adults 18 years and ...

African health-care workers fighting the rapid spread of a virulent mpox strain will learn how to effectively scratch under ...

Several hundred high-risk individuals were inoculated in Rwanda. Meanwhile, the Africa Centres for Disease Control and Prevention warned that the outbreak in Africa is still not under control, with ...

Mpox, declared a global public health emergency by WHO, has disproportionately affected children and adolescents ...

Mpox (formerly known as monkeypox) is back in the news. As of early September, the World Health Organization has reported ...

With more than 200 mpox-related deaths reported globally, the EMA has approved Imvanex for adolescents aged 12-17 years.

The NHS England has announced the routine commissioning of Daiichi Sankyo's quizartinib for acute myeloid leukaemia (AML).

COPENHAGEN, Denmark I 19, 2024 I Bavarian Nordic A/S (OMX: BAVA) announced today that the European Commission has adopted the Committee for ...